High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$2.0M
$2,043,941
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
XLO
P
Xilio Therapeutics, Inc.
Shannon James Samuel
• Director
Discretionary BuyΔOwn +100.0%
2026-03-26
$43,950
|
||||||
| XLO |
Xilio Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +100.0%
|
2026-03-26 | $43,950 | P | Form 4 |
|
XLO
P
Xilio Therapeutics, Inc.
GILEAD SCIENCES, INC.
• 10% Owner
Discretionary BuyΔOwn +10.2%
2026-02-13
$1,999,991Large
|
||||||
| XLO |
Xilio Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +10.2%
|
2026-02-13 | $1,999,991Large | P | Form 4 |